Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 3/20 | 0.68 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.68 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.68 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.68 |
| ▸ | NPC1 | O15118 | 1/20 | 0.68 |
| ▸ | HPGD | P15428 | 1/20 | 0.68 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.68 |
| ▸ | RAB9A | P51151 | 1/20 | 0.68 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.37 |
| ▸ | CHRM4 | P08173 | 2/20 | 0.37 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.37 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.37 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.37 |
| ▸ | HRH1 | P35367 | 4/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | SCN1A | P35498 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.35 |
| ▸ | SCN3A | Q9NY46 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10326821 | 1.00 | CYP2D6 (0.68) | CYP2D6CYP1A2CYP2C19KDM4ENPC1 | |
| SCHEMBL10326921 | 1.00 | CYP2D6 (0.68) | CYP2D6CYP1A2CYP2C19KDM4ENPC1 | |
| SCHEMBL9160008 | 0.95 | RAB9A (0.61) | CYP2D6CYP1A2CYP2C19KDM4ENPC1 | |
| SCHEMBL9160002 | 0.95 | RAB9A (0.61) | CYP2D6CYP1A2CYP2C19KDM4ENPC1 | |
| SCHEMBL10326845 | 0.86 | CYP2D6 (0.68) | CYP2D6CYP1A2CYP2C19KDM4ENPC1 | |
| SCHEMBL9230454 | 0.86 | CYP2D6 (0.68) | CYP2D6CYP1A2CYP2C19KDM4ENPC1 | |
| SCHEMBL20833288 | 0.85 | RAB9A (0.53) | CYP2D6CYP1A2CYP2C19KDM4ENPC1 | |
| SCHEMBL20832974 | 0.85 | RAB9A (0.53) | CYP2D6CYP1A2CYP2C19KDM4ENPC1 | |
| SCHEMBL22260353 | 0.85 | RAB9A (0.53) | CYP2D6CYP1A2CYP2C19KDM4ENPC1 | |
| SCHEMBL25973085 | 0.85 | RAB9A (0.53) | CYP2D6CYP1A2CYP2C19KDM4ENPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8217204-B2 | Catalyst for asymmetric hydrogenation | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2012-07-10 | — | — | US | disclosed |
| US-20100324338-A1 | CATALYST FOR ASYMMETRIC HYDROGENATION | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2010-12-23 | — | — | US | disclosed |
| EP-0657425-A1 | Process for the preparation of chiral aminoalcohols | Degussa Aktiengesellschaft (DE) | 1995-06-14 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100324338-A1 | CATALYST FOR ASYMMETRIC HYDROGENATION | H1-0, H1-5, ADH5 | CYP2D6 1125/4885CYP1A2 1183/4885CYP2C19 2363/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.